DK1347974T3 - Aminotriazolopyridinderivater som adenosinreceptorligander - Google Patents

Aminotriazolopyridinderivater som adenosinreceptorligander

Info

Publication number: DK1347974T3
Authority: DK; Denmark
Prior art keywords: aminotriazolopyridine; derivatives; receptor ligands; adenosine receptor; adenosine
Prior art date: 2000-12-15

Application number

DK01991804T

Other languages

English (en)

Inventor

Bernd Brodbeck

Matthias Heinrich Nettekoven

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-15

Filing date

2001-12-07

Publication date

2005-03-14

2001-12-07 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2005-03-14 Application granted granted Critical

2005-03-14 Publication of DK1347974T3 publication Critical patent/DK1347974T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Addiction (AREA)
Cardiology (AREA)
Psychology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Anesthesiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

DK01991804T 2000-12-15 2001-12-07 Aminotriazolopyridinderivater som adenosinreceptorligander DK1347974T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP00127567		2000-12-15
PCT/EP2001/014399 WO2002048145A1 (en)	2000-12-15	2001-12-07	Aminotriazolopyridiine derivatives as adenosine receptor ligands
EP01991804A EP1347974B1 (en)	2000-12-15	2001-12-07	Aminotriazolopyridiine derivatives as adenosine receptor ligands

Publications (1)

Publication Number	Publication Date
DK1347974T3 true DK1347974T3 (da)	2005-03-14

Family

ID=8170683

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01991804T DK1347974T3 (da)	2000-12-15	2001-12-07	Aminotriazolopyridinderivater som adenosinreceptorligander

Country Status (21)

Country	Link
US (1)	US6506772B1 (da)
EP (1)	EP1347974B1 (da)
JP (1)	JP4049672B2 (da)
KR (1)	KR100540628B1 (da)
CN (1)	CN1221551C (da)
AR (1)	AR031799A1 (da)
AT (1)	ATE281456T1 (da)
AU (2)	AU3167402A (da)
BR (1)	BR0116193A (da)
CA (1)	CA2437006C (da)
DE (1)	DE60106974T2 (da)
DK (1)	DK1347974T3 (da)
ES (1)	ES2230387T3 (da)
GT (1)	GT200100253A (da)
MX (1)	MXPA03005334A (da)
PA (1)	PA8534701A1 (da)
PE (1)	PE20020666A1 (da)
PT (1)	PT1347974E (da)
UY (1)	UY27074A1 (da)
WO (1)	WO2002048145A1 (da)
ZA (1)	ZA200304481B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4101755B2 (ja) *	2001-10-08	2008-06-18	エフ．ホフマン−ラロシュアーゲー	８−アミノ−〔１，２，４〕トリアゾロ〔１，５−ａ〕ピリジン−６−カルボン酸アミド
AU2003270701B2 (en) *	2002-10-31	2009-11-12	Amgen Inc.	Antiinflammation agents
KR101389246B1 (ko)	2004-07-15	2014-04-24	브리스톨-마이어스스퀴브컴파니	아릴- 및 헤테로아릴-치환된 테트라히드로이소퀴놀린, 및 이것의 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도
AU2007272009A1 (en) *	2006-07-12	2008-01-17	Syngenta Limited	Triazolopyridine derivatives as herbicides
US9156812B2 (en)	2008-06-04	2015-10-13	Bristol-Myers Squibb Company	Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
ES2446971T3 (es)	2009-05-12	2014-03-11	Albany Molecular Research, Inc.	Tetrahidroisoquinolinas sustituidas con arilo, heteroarilo, y heterociclo y su uso
ES2528404T3 (es)	2009-05-12	2015-02-10	Bristol-Myers Squibb Company	Formas cristalinas de (S)-7-([1,2,4]triazol[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina y sus usos
AU2010247763B2 (en) *	2009-05-12	2015-12-24	Albany Molecular Research, Inc.	7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof
WO2013043518A1 (en)	2011-09-22	2013-03-28	Merck Sharp & Dohme Corp.	Imidazopyridyl compounds as aldosterone synthase inhibitors
WO2013043520A1 (en) *	2011-09-22	2013-03-28	Merck Sharp & Dohme Corp.	Triazolopyridyl compounds as aldosterone synthase inhibitors
WO2020054712A1 (ja) *	2018-09-12	2020-03-19	日本化薬株式会社	有害生物防除剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9226735D0 (en)	1992-12-22	1993-02-17	Ici Plc	Azole derivatives
US5356894A (en)	1990-05-29	1994-10-18	Rodney Peter W	Morpholinyl substituted [1,2,4]-triazolo[1,5-a]triazine as antagonist
AU2639299A (en)	1998-02-24	1999-09-15	Kyowa Hakko Kogyo Co. Ltd.	Remedies/preventives for parkinson's disease
US6355653B1 (en)	1999-09-06	2002-03-12	Hoffmann-La Roche Inc.	Amino-triazolopyridine derivatives

2001
- 2001-11-30 US US09/998,323 patent/US6506772B1/en not_active Expired - Fee Related
- 2001-12-07 KR KR1020037008004A patent/KR100540628B1/ko not_active Expired - Fee Related
- 2001-12-07 CA CA002437006A patent/CA2437006C/en not_active Expired - Fee Related
- 2001-12-07 BR BR0116193-8A patent/BR0116193A/pt not_active Application Discontinuation
- 2001-12-07 PT PT01991804T patent/PT1347974E/pt unknown
- 2001-12-07 AU AU3167402A patent/AU3167402A/xx active Pending
- 2001-12-07 EP EP01991804A patent/EP1347974B1/en not_active Expired - Lifetime
- 2001-12-07 ES ES01991804T patent/ES2230387T3/es not_active Expired - Lifetime
- 2001-12-07 DE DE60106974T patent/DE60106974T2/de not_active Expired - Lifetime
- 2001-12-07 CN CNB018220304A patent/CN1221551C/zh not_active Expired - Fee Related
- 2001-12-07 WO PCT/EP2001/014399 patent/WO2002048145A1/en not_active Ceased
- 2001-12-07 AT AT01991804T patent/ATE281456T1/de active
- 2001-12-07 AU AU2002231674A patent/AU2002231674B2/en not_active Ceased
- 2001-12-07 DK DK01991804T patent/DK1347974T3/da active
- 2001-12-07 JP JP2002549676A patent/JP4049672B2/ja not_active Expired - Fee Related
- 2001-12-07 MX MXPA03005334A patent/MXPA03005334A/es active IP Right Grant
- 2001-12-12 PE PE2001001245A patent/PE20020666A1/es not_active Application Discontinuation
- 2001-12-12 AR ARP010105765A patent/AR031799A1/es unknown
- 2001-12-12 PA PA20018534701A patent/PA8534701A1/es unknown
- 2001-12-14 UY UY27074A patent/UY27074A1/es not_active Application Discontinuation
- 2001-12-14 GT GT200100253A patent/GT200100253A/es unknown
2003
- 2003-06-09 ZA ZA200304481A patent/ZA200304481B/en unknown

Also Published As

Publication number	Publication date
WO2002048145A1 (en)	2002-06-20
GT200100253A (es)	2002-07-31
DE60106974T2 (de)	2005-11-03
UY27074A1 (es)	2002-07-31
KR20030061446A (ko)	2003-07-18
EP1347974A1 (en)	2003-10-01
AR031799A1 (es)	2003-10-01
BR0116193A (pt)	2003-09-23
JP2004521096A (ja)	2004-07-15
CA2437006C (en)	2009-10-27
AU3167402A (en)	2002-06-24
CN1221551C (zh)	2005-10-05
AU2002231674B2 (en)	2006-07-06
ZA200304481B (en)	2004-09-09
JP4049672B2 (ja)	2008-02-20
PA8534701A1 (es)	2002-08-26
EP1347974B1 (en)	2004-11-03
MXPA03005334A (es)	2004-04-02
ES2230387T3 (es)	2005-05-01
PT1347974E (pt)	2005-02-28
PE20020666A1 (es)	2002-07-27
KR100540628B1 (ko)	2006-01-11
CN1486314A (zh)	2004-03-31
DE60106974D1 (de)	2004-12-09
US6506772B1 (en)	2003-01-14
CA2437006A1 (en)	2002-06-20
ATE281456T1 (de)	2004-11-15

Publication	Publication Date	Title
DK1414440T3 (da)	2007-05-21	N-phenylpyrrolguanidinderivater som melanocortinreceptorligander
NO20015477D0 (no)	2001-11-08	4,5,6,7-tetrahydroindazol-derivater som anti-tumor midler
NO20013671L (no)	2001-09-26	Substituerte bisycliske derivater nyttige som anticancer midler
NO20032531D0 (no)	2003-06-04	Tetralon-derivater som antitumormidler
ATE325807T1 (de)	2006-06-15	Purinderivate
DE60037345D1 (de)	2008-01-17	Pyrroloi2,3-d pyrimidinderivate enthaltende Zusammensetzungen
DK1292604T3 (da)	2009-06-15	2-Aminocarbonyl-9H-purinderivater
ATE267836T1 (de)	2004-06-15	Purinderivate
DK1280809T3 (da)	2005-11-07	Antitumorecteinascidinderivater
ATE298332T1 (de)	2005-07-15	Decahydro-isochinolinderivate
PL373953A1 (en)	2005-09-19	7-amino-benzothiazole derivatives as adenosine receptor ligands
ATE306265T1 (de)	2005-10-15	Benzothiazolderivate als adenosin-rezeptor- liganden
DK1322654T3 (da)	2009-04-14	Platinkomplekser som antitumormidler
ATE414056T1 (de)	2008-11-15	Substituierte c-cyclohexylmethylamin-derivative
DK1560828T3 (da)	2006-09-04	Imidazoquinolinderivater som adenosin-A3-receptorligander
NO20043119L (no)	2004-07-20	Triazolokinolinderivater som kan anvendes som adenosinreseptorligander
DK1347974T3 (da)	2005-03-14	Aminotriazolopyridinderivater som adenosinreceptorligander
ATE282021T1 (de)	2004-11-15	Substituierte aminomethyl-phenyl- cyclohexanderivate
DK1322593T3 (da)	2004-10-11	O-substituerede-6-methyl-tramadol-derivater
ATE280752T1 (de)	2004-11-15	Aminomethyl-phenyl-cyclohexanonderivate
ATE374776T1 (de)	2007-10-15	Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no)	2002-09-13	2-fenylpyran-4-on-derivater
DK1177185T3 (da)	2005-06-06	4,5,6,7-tetrahydroindazolderivater som antitumormidler
DK1345892T3 (da)	2005-06-27	Acylaminoalkylsubstituerede benzensulfonamidderivater